Sunday, March 16, 2025 | 11:35 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

South Korea allows use of Gilead's remdesivir to treat Covid-19 patients

The South Korean government's fast-track import approval on Wednesday came after health authorities concluded that the drug could possibly help patients recover faster

Gene Campbell, 89, who contracted Covid-19 at Life Care Center of Kirkland in early March, sits in his son Todd's car as he leaves Swedish Medical Center Edmonds after spending six weeks in the hospital in Edmonds, Washington. Photo: Reuters
Premium

Officials plan to soon hold discussions with Gilead to arrange the drug shipments.

BS Web TeamAgencies
South Korea's Food and Drug Safety Ministry has allowed the use of Gilead Sciences' antiviral drug remdesivir in treatment of Covid-19 patients.

The ministry's fast-track import approval on Wednesday came after health authorities concluded that the drug could possibly help patients recover faster.

Officials plan to soon hold discussions with Gilead to arrange the drug shipments.


The US food and drug regulatory body has allowed emergency use of an investigational anti-viral vaccine to treat Covid-19 patients after some researches, including one led by

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in